Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Petrou

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Molecular Neurodegeneration|September 27, 2023
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's diseaseAmanda L Wright, Lyndsey M Konen, Bruce G Mockett, et al.
JCI Insight|September 29, 2022
Antisense oligonucleotide therapy for KCNT1 encephalopathyLisseth Estefania Burbano, Melody Li, Nikola Jancovski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2007
Reduced cortical inhibition in a mouse model of familial childhood absence epilepsyHeneu O Tan, Christopher A Reid, Frank N Single, et al.
Neurology|April 1, 2016
A targeted resequencing gene panel for focal epilepsyMichael S Hildebrand, Candace T Myers, Gemma L Carvill, et al.
The Journal of Clinical Investigation|July 15, 2010
Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plusVerena C Wimmer, Christopher A Reid, Suzanne Mitchell, et al.
The Journal of Clinical Investigation|December 1, 2021
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy modelMelody Li, Nikola Jancovski, Paymaan Jafar-Nejad, et al.
Neurology|October 14, 2016
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsyMark A Corbett, Susannah T Bellows, Melody Li, et al.
Brain : a Journal of Neurology|October 6, 2006
Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutationsIngrid E Scheffer, Louise A Harkin, Bronwyn E Grinton, et al.
Epilepsia|March 26, 2018
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsyTalia A Atkin, Chani M Maher, Aaron C Gerlach, et al.
Neurology. Genetics|December 28, 2018
Development of a rapid functional assay that predicts GLUT1 disease severitySasha M Zaman, Saul A Mullen, Slavé Petrovski, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Molecular Neurodegeneration|September 27, 2023
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's diseaseAmanda L Wright, Lyndsey M Konen, Bruce G Mockett, et al.
JCI Insight|September 29, 2022
Antisense oligonucleotide therapy for KCNT1 encephalopathyLisseth Estefania Burbano, Melody Li, Nikola Jancovski, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2007
Reduced cortical inhibition in a mouse model of familial childhood absence epilepsyHeneu O Tan, Christopher A Reid, Frank N Single, et al.
Neurology|April 1, 2016
A targeted resequencing gene panel for focal epilepsyMichael S Hildebrand, Candace T Myers, Gemma L Carvill, et al.
The Journal of Clinical Investigation|July 15, 2010
Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plusVerena C Wimmer, Christopher A Reid, Suzanne Mitchell, et al.
The Journal of Clinical Investigation|December 1, 2021
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy modelMelody Li, Nikola Jancovski, Paymaan Jafar-Nejad, et al.
Neurology|October 14, 2016
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsyMark A Corbett, Susannah T Bellows, Melody Li, et al.
Brain : a Journal of Neurology|October 6, 2006
Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutationsIngrid E Scheffer, Louise A Harkin, Bronwyn E Grinton, et al.
Epilepsia|March 26, 2018
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsyTalia A Atkin, Chani M Maher, Aaron C Gerlach, et al.
Neurology. Genetics|December 28, 2018
Development of a rapid functional assay that predicts GLUT1 disease severitySasha M Zaman, Saul A Mullen, Slavé Petrovski, et al.
Pageof 19